Side-by-side comparison of AI visibility scores, market position, and capabilities
Global PE and alternatives firm with $638B AUM; Global Atlantic insurance engine funds credit strategies; major AI infrastructure investor; NYSE: KKR with corporation conversion 2021.
KKR & Co. is one of the world's leading global investment firms, founded in 1976 by Jerome Kohlberg, Henry Kravis, and George Roberts in New York City—pioneers of the leveraged buyout era. The firm trades on NYSE (KKR) and manages approximately $638 billion in assets under management as of late 2024, spanning private equity, credit and liquid strategies, real assets, infrastructure, and real estate. KKR's 2021 conversion from a partnership to a corporation simplified its ownership structure and broadened its investor base, driving significant stock appreciation as AUM growth compounded.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.